-
KOSPI 2577.27 -2.21 -0.09%
-
KOSDAQ 722.52 -7.07 -0.97%
-
KOSPI200 341.49 +0.02 +0.01%
-
USD/KRW 1396 -2.00 0.14%
NMPA
Search results
-
Bio & Pharma SK Biopharm submits NDA of epilepsy drug to ChinaSouth Korea's SK Biopharmaceuticals Co. said on Tuesday it submitted the new drug application (NDA) for its flagship epilepsy drug Cenobamate to Chi...
Dec 05, 2024 (Gmt+09:00)
